Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Neurology · JAMA · 2026-11-17
RCTn = 410
Brakedal et al. Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical TrialNeurology · Lancet Neurol · 2026-08-01
RCTn = 304
Fernandez et al. Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trialNeurology · JAMA Neurol · 2026-07-01
Meta-analysisn = 900
Virameteekul et al. Phenoconversion in Pure Autonomic Failure: A Systematic Review and Meta-AnalysisNeurology · Neurology · 2026-06-16
Meta-analysisn = 220
Pereira et al. Fecal Microbiota Transplantation in Parkinson Disease: A Systematic Review, Meta-Analysis, and Meta-RegressionNeurology · Mov Disord · 2026-06-01
RCTn = 30
Matt et al. Transcranial Pulse Stimulation Enhances Dexterity in Parkinson's Disease: A Randomized Sham-Controlled TrialNeurology · Lancet · 2026-05-30
RCTn = 586
Nikolcheva et al. Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled studyNeurology · Mov Disord · 2026-05-24
RCTn = 27
Lin et al. Deep Brain Stimulation of the Posterior Subthalamic Area and the Subthalamic Nucleus in Tremor-Dominant Parkinson's Disease: A Randomized, Crossover TrialNeurology · Mov Disord · 2026-05-09
RCTn = 140 patients
Peng et al. Qihuang Needle Therapy for Motor Symptoms in Parkinson's Disease: A Randomized Controlled TrialNeurology · JAMA Neurol · 2026-05-01
RCTn = 507
Fernandez et al. Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical TrialNeurology · JAMA Neurol · 2026-05-01
RCTn = 529
Pahwa et al. Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical TrialNeurology · Mov Disord · 2026-04-30
Meta-analysisn = 184 studies
Tripoliti et al. Speech and Deep Brain Stimulation in Parkinson's Disease, Essential Tremor, and Dystonia: A Systematic Review and Meta-analysisNeurology · Mov Disord · 2026-04-30
RCTn = 23
Xu et al. Temporal Interference Stimulation Modulates Resting State Functional Connectivity of Motor Circuit in Parkinson's DiseaseNeurology · Mov Disord · 2026-04-11
Meta-analysisn = 883
Macleod et al. Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence CohortsNeurology · Neurology · 2026-04-09
Meta-analysisn = 6,410
Del Papa et al. Neurovascular Unit Dysfunction and Cerebral Small Vessel Disease in Parkinson Disease: A Systematic Review and a Meta AnalysisNeurology · Ann Neurol · 2026-02-12
RCTn = 59 patients
Figura et al. Safety and Efficacy of Fecal Microbiota Transplantation in Alleviating Symptoms of Parkinson's Disease: A Randomized, Placebo-Controlled, Double-Blinded StudyNeurology · Eur J Neurol · 2026-02-01
Meta-analysisn = 725
Burton et al. Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta-AnalysisNeurology · Mov Disord · 2026-01-30
Meta-analysisn = 2,136
Rajai Firouzabadi et al. Hearing Loss in Parkinson's Disease: A Systematic Review and Meta-AnalysisNeurology · Mov Disord · 2026-01-24
Meta-analysisn = 16 studies
Hemeda et al. Impact of Alcohol Intake on Parkinson's Disease Risk and Progression: A Systematic Review and Dose-Response Meta-Analysis of Prospective StudiesNeurology · Eur J Neurol · 2026-01-01
Meta-analysisn = 23 studies
Theyer et al. The Utility of Olfactory Testing to Discriminate Parkinson's Disease From Diagnostic Mimics: A Systematic Review and Meta-AnalysisNeurology · Lancet Neurol · 2026-01-01
RCTn = 66
Greenland et al. Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial